|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-1.20/-1.91
|
企業價值
1.09B
|
資產負債 |
每股賬面淨值
0.42
|
現金流量 |
現金流量率
--
|
損益表 |
收益
1.70M
|
每股收益
0.02
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/17 02:39 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3,AUTO5, AUTO6, AUTO7 & AUTO8. |